Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki-67 expression

Hepatology

Volumn 29, Issue 6, 1999, Pages 1722-1729

  Yamagata, M ^a   Masaki, T ^a   Okudaira, T ^a   Imai, Y ^a   Shiina, S ^a   Shiratori, Y ^a   Omata, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER SCREENING; CHRONIC LIVER DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; ULTRASOUND;

EID: 0032991095     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290606     Document Type: Article

References (54)

1. 1 The liver cancer study group of Japan. Primary liver cancer in Japan: clinicopathological features and results of surgical treatment. Ann Surg 1990 ; 211: 277–287. MEDLINE
2. 2 Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 1985 ; 56: 918–928. MEDLINE
3. 3 Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986 ; 6: 729–738. MEDLINE
4. 4 Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR 1990 ; 155: 49–54.
5. 5 Hirai K, Aoki Y, Majima Y, Abe H, Nakashima O, Kojiro M, Tanikawa K. Magnetic resonance imaging of small hepatocellular carcinoma. Am J Gastroenterol 1991 ; 86: 205–209. MEDLINE
6. 6 Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, Tsuchiya Y, et al. Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real‐time ultrasonography. Gastroenterology 1984 ; 86: 495–502. MEDLINE
7. 7 Sheu JC, Sung JL, Chen DS, Yu JY, Wang TH, Su CT, Tsang YM. Ultrasonography of small hepatic tumors using high‐resolution linear‐array real‐time instruments. Radiology 1984 ; 150: 797–802. MEDLINE
8. 8 Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K. Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990 ; 12: 680–687. MEDLINE
9. 9 Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR 1993 ; 160: 1023–1028.
10. 10 Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, Miyayama S, et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. Radiology 1993 ; 188: 79–83. MEDLINE
11. 11 Shiratori Y, Shiina S, Imamura M, Kato N, Kanai F, Okudaira T, Teratani T, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B‐ and C‐viral infection in Japan. Hepatology 1995 ; 22: 1027–1033. MEDLINE
12. 12 Tanaka S, Kitamura T, Nakanishi K, Okuda S, Kojima J, Fujimoto I. Recent advances in ultrasonographic diagnosis of hepatocellular carcinoma. Cancer 1989 ; 63: 1313–1317. MEDLINE
13. 13 Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Morita M, et al. Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: a study in 22 patients. Gastroenterology 1986 ; 90: 289–298. MEDLINE
14. 14 McMahon BJ, London T. Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991 ; 83: 916–919. MEDLINE
15. 15 Mima S, Sekiya C, Kanagawa H, Kohyama H, Gotoh K, Mizuno H, Ijiri M, et al. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 1994 ; 9: 361–365. MEDLINE
16. 16 Taboury J, Porcel A, Tubiana JM, Monnier JP. Cavernous hemangiomas of the liver studied by ultrasound. Radiology 1983 ; 149: 781–785. MEDLINE
17. 17 Bree RL, Schwab RE, Neiman HL. Solitary echogenic spot in the liver: is it diagnostic of a hemangioma? AJR 1983 ; 140: 41–45.
18. 18 Gibney RG, Hendin AP, Cooperberg PL. Sonographically detected hepatic hemangiomas: absence of change over time. AJR 1987 ; 149: 953–957.
19. 19 Kimura Y, Fukada R, Katagiri S, Matsuda Y. Evaluation of hyperechoic liver tumors in MHTS. J Med Systems 1993 ; 17: 127–132.
20. 20 Itai Y, Ohtomo K, Araki T, Furui S, Iio M, Atomi Y. Computed tomography and sonography of cavernous hemangioma of the liver. AJR 1983 ; 141: 315–320.
21. 21 Stark DD, Felder RC, Wittenberg J, Saini S, Butch RJ, White ME, Edelman RR, et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue‐specific characterization. AJR 1985 ; 145: 213–222.
22. 22 Johnson CM, Sheedy PF, Stanson AW, Stephens DH, Hattery RR, Adson MA. Computed tomography and angiography of cavernous hemangiomas of the liver. Radiology 1981 ; 138: 115–121. MEDLINE
23. 23 Okuda K. The patient with a suspicious liver mass. In: Terblanche PJ, ed. Hepatobiliary Malignancy. Its Multidisciplinary Management. London: Edward Arnold, 1994 ; 27–50.
24. 24 Itai Y, Ohtomo K, Ohnishi S, Atomi Y, Itoh T, Fukuhisa K, Iinuma T. Ultrasonography of small hepatic tumors. Radiat Med 1987 ; 5: 14–19. MEDLINE
25. 25 International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995 ; 22: 983–993. MEDLINE
26. 26 Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994 ; 19: 1513–1520. MEDLINE
27. 27 Bartek J, Bartkova J, Lukas J, Staskova Z, Vojtesk B, Lane DP. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 1993 ; 169: 27–34. MEDLINE
28. 28 Key G, Becker MH, Baron B, Duchrow M, Schluter C, Flad HD, Gerdes J. New Ki‐67‐equivalent murine monoclonal antibodies (MIB1–3) generated against bacterially expressed parts of the Ki‐67 cDNA containing three 62 base pair repetitive elements encoding for the Ki‐67 epitope. Lab Invest 1993 ; 68: 629–636. MEDLINE
29. 29 Lan FQ, Irene OLNG, Sheung TF, Matthew NG. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer (Pred Oncol) 1998 ; 79: 424–428.
30. 30 Hunyady B, Krempels K, Harta G, Mezey E. Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem 1996 ; 44: 1353–1362. MEDLINE
31. 31 Tanaka S, Kitamura T, Imaoka S, Sasaki Y, Taniguchi H, Ishiguro S. Hepatocellular carcinoma; sonographic and histologic correlation. Am J Roentgenol 1983 ; 140: 701–707.
32. 32 Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 1992 ; 15: 843–848. MEDLINE
33. 33 Terada T, Nakanuma Y, Hoso M, Saito K, Sasaki M, Nonomura A. Fatty macroregenerative nodule in non‐steatotic liver cirrhosis. A morphologic study. Virchows Archiv A Pathol Anat 1989 ; 415: 131–136.
34. 34 Motohashi I, Okudaira M, Takai T, Kaneko S, Ikeda N. Morphological differences between hepatocellular carcinoma and hepatocellular carcinomalike lesions. Hepatology 1992 ; 16: 118–126. MEDLINE
35. 35 Terada T, Ueda K, Nakanuma Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Virchows Archiv A Pathol Anat 1993 ; 422: 381–388.
36. 36 Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991 ; 22: 172–178. MEDLINE
37. 37 Sato M, Watanabe Y, Lee T, Kito K, Kimura S, Itoh Y, Akamatsu K, et al. Well‐differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection. Am J Gastroenterol 1995 ; 90: 112–116. MEDLINE
38. 38 Ota G. Small HCC with severe fat deposition. Nakashima T, et al., eds. Hepatic Lesions Resembling Hepatocellular Carcinoma. Tokyo: Chugai. 1984 ; 203–222.
39. 39 Wada K, Kondo F, Kondo Y. Large regenerative nodules and dysplastic nodules in cirrhotic livers: a histopathologic study. Hepatology 1988 ; 8: 1684–1688. MEDLINE
40. 40 Kondo F, Ebara M, Suguhara N, Wada K, Kita K, Hirooka N, Nagato Y, et al. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990 ; 12: 592–598. MEDLINE
41. 41 Edmondson HA. Tumours of the liver and intrahepatic bile ducts. Atlas of Tumor Pathology. Washington DC: Armed Forces Institute of Pathology. 592–598.
42. 42 Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981 ; 47: 2746–2755. MEDLINE
43. 43 Wu PC, Lai CL, Lam KC, Lok ASF, Lin HJ. Clear cell carcinoma of liver. An ultrastructural study. Cancer 1983 ; 52: 504–507. MEDLINE
44. 44 Kenmochi K, Sugihara S, Kojiro M. Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver 1987 ; 7: 18–26. MEDLINE
45. 45 Terada T, Ueda K, Nakanuma Y. Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers. Virchows Arch A Pathol Anat 1993 ; 422: 381–388.
46. 46 Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 1994 ; 54: 3107–3110. MEDLINE
47. 47 Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation–associated human nuclear antigen defined by monoclonal antibody Ki‐67. J Immunol 1984 ; 133: 1710–1715. MEDLINE
48. 48 Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991 ; 350: 429–431. MEDLINE
49. 49 Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991 ; 350: 427–428. MEDLINE
50. 50 Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994 ; 54: 231–235. MEDLINE
51. 51 Buetow KH, Sheffield VC, Zhu M, Zhou T, Shen FM, Hino O, Smith M, et al. Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinoma. Proc Natl Acad Sci U S A 1992 ; 89: 9622–9626. MEDLINE
52. 52 Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Okazaki N, Takayasu K, Kosuge T, et al. Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990 ; 336: 1150–1153. MEDLINE
53. 53 Borzio M, Borzio F, Croce A, Sala M, Salmi A, Leandro G, Gruno S, et al. Ultrasonography‐detected macroregenerative nodules in cirrhosis: a prospective study. Gastroenterology 1997 ; 112: 1617–1623. MEDLINE
54. 54 Terasaki S, Kaneko S, Kobayashi K, Nonomura A, Nakanuma Y. Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998 ; 115: 1216–1222. MEDLINE